FOB Price
Get Latest Price( Negotiable )
|Minimum Order
Place of Origin:
China
Price for Minimum Order:
-
Minimum Order Quantity:
2000 Piece
Packaging Detail:
1 test and a desiccant per foil pouch, box, carton
Delivery Time:
according to your quantity
Supplying Ability:
1000000 Piece per Month
Payment Type:
T/T, Western Union, Other
連絡先担当者 Ms. ellen
Room 506, High-tech Innovation Center, Zhongyang Road,, Nantong, Jiangsu
Our company specialized in researching, developing, manufacturing and distributing advanced medical instruments and in-vitro medical diagnostic products.
product use: Troponin I test CK-MB test Myoglobin test
Troponin I test:
Cardiac Troponin (cTnl) is a protein found in cardiac muscle with a molecular weight of *2.5 kDa.Troponin I is part of a three subunit complex comprising of Troponin T and Troponin C. Along with tropomyosin, this structural complex forms the main component that regulates the calcium sensitive ATPase activity of actomyosin in striated skeletal and cardiac muscle. After cardiac injury occurs, Troponin I is released into the blood **6 hours after the onset of pain. The release pattern of cardiac Tnl is similar to CK-MB, but while CK-MB levels return to normal after *2 hours, Troponin I remains elevates for ***0 days, thus providing for a longer window of detection for cardiac injury. The high specificity of cTnl measurements for the identification of myocardial damage has been demonstrated in conditions such as the perioperative period, after marathon runs, and blunt chest trauma. cTnl release has also been documented in cardiac conditions other than acute myocardial infarction /AMI) such as unstable angina congestive heart failure, and ischemic damage due to coronary artery bypass surgery.Because of its high specificity and sensitivity in the myocardial tissue, Troponin I has recently become the most preferred biomarker for myocardial infarction.Troponin I (cTnl) Test is a simple test that utilizes a combination of colloidal gold conjugate, biotinylated anti-cTnl antibodies and streptavidin to selectively detect cTnl in whole blood, serum or plasma. The minimumdetection level is 0.5 ng/mL.
CK-MB test :
CK–MB levels, along with total CK, are tested in persons who have chest pain to diagnose whether they have had a heart attack. Since a high total CK could indicate damage to either the heart or other muscles, CK–MB helps to distinguish between these two sources. If your doctor thinks you have had a heart attack and gives you a “clot-dissolving” drug, CK–MB can help your doctor tell if the drug worked. When the clot dissolves, CK–MB tends to rise and fall faster. By measuring CK–MB in blood several times, your doctor can usually tell whether the drug has been effective.
Myoglobin test:
Myoglobin may be ordered as a cardiac biomarker, along with troponin, to help diagnose or rule out a heart attack.
of myoglobin start to rise within **3 hours of a heart attack or other muscle injury, reach their highest levels within
***2 hours, and gennerally fall back to normal within one day.